Davis PJ - Search Results

1

Stryker ZI, Rajabi M, Davis PJ, Mousa SA. Stryker ZI, et al. Among authors: davis pj. Biomedicines. 2019 May 16;7(2):37. doi: 10.3390/biomedicines7020037. Biomedicines. 2019. PMID: 31100863 Free PMC article. Review.

2

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.

Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ. Davis FB, et al. Among authors: davis pj. Circ Res. 2004 Jun 11;94(11):1500-6. doi: 10.1161/01.RES.0000130784.90237.4a. Epub 2004 Apr 29. Circ Res. 2004. PMID: 15117822

3

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis.

Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Bergh JJ, et al. Among authors: davis fb, davis pj. Endocrinology. 2005 Jul;146(7):2864-71. doi: 10.1210/en.2005-0102. Epub 2005 Mar 31. Endocrinology. 2005. PMID: 15802494

4

The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin.

Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ. Mousa SA, et al. Among authors: davis fb, davis pj. J Cardiovasc Pharmacol. 2005 Sep;46(3):356-60. doi: 10.1097/01.fjc.0000175438.94906.a0. J Cardiovasc Pharmacol. 2005. PMID: 16116342

5

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated.

Mousa SA, O'Connor L, Davis FB, Davis PJ. Mousa SA, et al. Among authors: davis fb, davis pj. Endocrinology. 2006 Apr;147(4):1602-7. doi: 10.1210/en.2005-1390. Epub 2005 Dec 29. Endocrinology. 2006. PMID: 16384862

6

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells.

Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY. Davis FB, et al. Among authors: davis pj. Cancer Res. 2006 Jul 15;66(14):7270-5. doi: 10.1158/0008-5472.CAN-05-4365. Cancer Res. 2006. PMID: 16849576

7

Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.

Mousa SA, Davis FB, Mohamed S, Davis PJ, Feng X. Mousa SA, et al. Among authors: davis fb, davis pj. Int Angiol. 2006 Dec;25(4):407-13. Int Angiol. 2006. PMID: 17164749

8

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.

Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ. Mousa SA, et al. Among authors: davis fb, davis pj. Angiogenesis. 2008;11(2):183-90. doi: 10.1007/s10456-007-9088-7. Epub 2007 Dec 13. Angiogenesis. 2008. PMID: 18080776

9

Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.

Rebbaa A, Chu F, Davis FB, Davis PJ, Mousa SA. Rebbaa A, et al. Among authors: davis fb, davis pj. Angiogenesis. 2008;11(3):269-76. doi: 10.1007/s10456-008-9110-8. Epub 2008 Apr 4. Angiogenesis. 2008. PMID: 18386142

10

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.

Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ. Lin HY, et al. Among authors: davis fb, davis pj. Am J Physiol Cell Physiol. 2009 May;296(5):C980-91. doi: 10.1152/ajpcell.00305.2008. Epub 2009 Jan 21. Am J Physiol Cell Physiol. 2009. PMID: 19158403 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

706 results

Search Page